-
31.
公开(公告)号:HUE032813T2
公开(公告)日:2017-11-28
申请号:HUE06848237
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
-
32.
公开(公告)号:PL1993360T3
公开(公告)日:2017-08-31
申请号:PL06848237
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/56 , A61K31/445
-
33.
公开(公告)号:AU2016219571A1
公开(公告)日:2016-09-08
申请号:AU2016219571
申请日:2016-08-23
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , CONNELLY PATRICK , ROWE WILLIAM , YOUNG CHRISTOPHER R , COSTACHE ADRIANA , KRAWIEC MARIUSZ , GONG YUCHUAN , FENG YUSHI , TRUDEAU MARTIN
IPC: A61K31/445
Abstract: The present invention relates to solid state forms of N-[2,4-bis(1,1 -dimethylethyl)-5 hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.
-
公开(公告)号:BR112012008082A2
公开(公告)日:2016-03-01
申请号:BR112012008082
申请日:2010-02-18
Applicant: VERTEX PHARMA
-
公开(公告)号:ZA201200722B
公开(公告)日:2013-05-29
申请号:ZA201200722
申请日:2012-01-30
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER R , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , ZLOKARNIK GREGOR , VAN GOOR FREDRICK F
IPC: A61K20060101 , A61P20060101
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:AU2010282986A1
公开(公告)日:2012-02-16
申请号:AU2010282986
申请日:2010-02-18
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER R , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , ZLOKARNIK GREGOR , VAN GOOR FREDRICK F
Abstract: The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis( 1, 1 -dimethylethyl)-5-hydroxyphenyl]- 1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
-
公开(公告)号:HK1129581A1
公开(公告)日:2009-12-04
申请号:HK09107790
申请日:2009-08-25
Applicant: VERTEX PHARMA
Inventor: YOUNG CHRISTOPHER R , ROWE CHARLES WILLIAM
IPC: A61K20060101
-
公开(公告)号:CY1122861T1
公开(公告)日:2021-05-05
申请号:CY201100244
申请日:2020-03-17
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/56 , A61K31/445
Abstract: ΗπαρούσαεφεύρεσηαφοράσεστερεάςκατάστασηςμορφέςτουΝ-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδίου (Ένωση 1), φαρμακευτικέςσυνθέσειςαυτούκαιμεθόδουςμεαυτό.
-
公开(公告)号:PL3219705T3
公开(公告)日:2020-08-10
申请号:PL17154944
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN , HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA
IPC: C07D215/56 , A61K31/445
-
公开(公告)号:CY1121572T1
公开(公告)日:2020-05-29
申请号:CY191100385
申请日:2019-04-08
Applicant: VERTEX PHARMA
Inventor: ROWE WILLIAM , HURTER PATRICIA , YOUNG CHRISTOPHER R , DINEHART KIRK , VERWIJS MARINUS JACOBUS , OVERHOFF KIRK , GROOTENHUIS PETER D J , BOTFIELD MARTYN , GROSSI ALFREDO , ZLOKARNIK GREGOR , VAN GOOR FREDRICK F
Abstract: ΗπαρούσαεφεύρεσηαφοράσεφαρμακευτικέςσυνθέσειςπουπεριλαμβάνουνδιασποράστερεούτουΝ-[2,4-Δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3 καρβοξαμιδίου, μεθόδουςβιομηχανικήςκατασκευήςφαρμακευτικώνσυνθέσεωντηςπαρούσαςεφεύρεσηςκαιμεθόδουςχορήγησηςφαρμακευτικώνσυνθέσεωντηςπαρούσαςεφεύρεσης.
-
-
-
-
-
-
-
-
-